Drug: Ranolazine: chronic pain clinical trials

Registry records that list "Drug: Ranolazine" as an intervention. Being studied does not mean an intervention works or is approved.

Trials with Canadian sites

Recruiting in Canada

Registry records in total

Trials in Canada

2 trials, 0 recruiting or not yet recruiting. Recruiting first.

		Phase	Provinces
Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI) NCT01442038	Completed	Phase 3	Alberta, New Brunswick, Ontario, Quebec	Gilead Sciences	2011-10
Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina NCT01425359	Completed	Phase 4	Ontario, Quebec	Gilead Sciences	2011-09

8 trials, 0 recruiting or not yet recruiting. Recruiting first.

		Phase	Countries
Management of Ischemic Heart Disease With Angiwell-XR (Ranolazine) NCT03486561	Unknown status	Phase 4		OBS Pakistan	2018-04-01
Efficacy of Ranolazine in Patients With Chronic Total Occlusions of Coronary Arteries NCT02423265	Withdrawn	Phase 4	United States	East Carolina University	2015-06
Ranolazine Among Unrevascularized Chronic Stable Angina Patients NCT02265796	Completed	Phase 2	United States	North Florida Foundation for Research and Education	2014-09
Effects of Ranolazine and Exercise on Daily Physical Activity Trial NCT01948310	Completed	Phase 4	United States	Duke University	2013-12
Safety of Amiodarone and Ranolazine Together in Patients With Angina NCT01558830	Unknown status	Phase 4	United States	Cardiovascular Consultants of Nevada	2012-01
A Study on the Effects of Ranolazine on Exercise Duration in Subjects With Chronic Stable Angina and Coronary Artery Disease (CAD) With Type 2 Diabetes Mellitus (T2DM) NCT01334203	Withdrawn	Phase 4		Gilead Sciences	2011-05
Ranolazine Versus Placebo Effects on Exercise Tolerance in Patients With Heart Disease and Peripheral Arterial Disease NCT00657514	Withdrawn	Phase 4	United States	Colorado Prevention Center	2008-05
Ranolazine SR in Patients With Chronic Angina Who Remain Symptomatic Despite Maximal Treatment With Amlodipine NCT00091429	Completed	Phase 3		Gilead Sciences	2004-08

Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status.